As of 5 Jul 2026, Dishman Carbo share price is ₹196.54. The stock opened at ₹188.70, compared to its previous close of ₹187.75. During today's trading session, Dishman Carbo share price moved in the range of ₹187.80 to ₹201.90, with an average price of ₹194.85 for the day. Looking at its last 52-week, the stock has touched a low of ₹128.50 and a high of ₹321.95. On the performance front, Dishman Carbo share price has declined by 22.86% over the last six months and is down 23.21% on a year-on-year basis.
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹2,711.50 | ₹2,615.77 | ₹2,412.92 | ₹2,140.69 |
| Other Income | ₹21.68 | ₹28.21 | ₹27.77 | ₹43.42 |
| Total Revenue | ₹2,733.18 | ₹2,643.98 | ₹2,440.69 | ₹2,184.11 |
| Total Expenses | ₹2,695.76 | ₹2,760.10 | ₹2,447.13 | ₹2,173.72 |
| Profit Before Tax | ₹19.31 | -₹122.26 | -₹54.59 | -₹4.25 |
| Tax | ₹16.07 | ₹31.19 | -₹24.79 | -₹22.26 |
| Profit After Tax | ₹3.24 | -₹153.45 | -₹29.80 | ₹18.01 |
| EPS - Basic | ₹0.21 | -₹9.79 | -₹1.90 | ₹1.15 |
| EPS - Diluted | ₹0.21 | -₹9.79 | -₹1.90 | ₹1.15 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹19.31 | -₹122.26 | -₹54.59 | -₹4.25 |
| Income before WC changes | ₹486.14 | ₹254.57 | ₹337.87 | ₹321.09 |
| Change in Assets | -₹208.14 | ₹55.74 | -₹245.81 | -₹145.62 |
| Change in Liabilities | ₹127.55 | ₹88.09 | ₹208.08 | ₹235.71 |
| Change in WC | -₹80.59 | ₹143.83 | -₹37.73 | ₹90.09 |
| Cash flow from Operations | ₹375.23 | ₹379.43 | ₹265.96 | ₹354.85 |
| Cash flow from Investing | -₹192.21 | -₹229.52 | -₹494.08 | -₹618.53 |
| Cash flow from Financing | -₹102.09 | -₹22.15 | ₹249.67 | ₹130.38 |
| Total Cash Flow | ₹80.93 | ₹127.76 | ₹21.55 | -₹133.30 |
| Cash (Start of the year) | ₹264.09 | ₹131.79 | ₹110.24 | ₹243.54 |
| Cash (End of the year) | ₹341.07 | ₹264.09 | ₹131.79 | ₹110.24 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹7,798.73 | ₹7,653.22 | ₹7,535.14 | ₹6,798.73 |
| Current Assets | ₹2,200.42 | ₹1,928.19 | ₹1,918.36 | ₹1,838.72 |
| Total Assets | ₹9,999.15 | ₹9,581.41 | ₹9,453.50 | ₹8,637.45 |
| Current Liabilities | ₹1,924.79 | ₹2,554.72 | ₹1,798.39 | ₹1,419.79 |
| Net Current Asset | ₹275.63 | -₹626.53 | ₹119.97 | ₹418.93 |
| Non-Current Liabilities | ₹2,242.84 | ₹1,399.19 | ₹1,845.44 | ₹1,668.72 |
| Equity Capital | ₹5,831.52 | ₹5,627.50 | ₹5,809.67 | ₹5,548.94 |
| Total Equity & Liabilities | ₹9,999.15 | ₹9,581.41 | ₹9,453.50 | ₹8,637.45 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹399.84 | ₹327.35 | ₹402.55 | ₹306.61 |
| Other Income | ₹32.98 | ₹63.05 | ₹52.16 | ₹60.39 |
| Total Revenue | ₹432.82 | ₹390.40 | ₹454.71 | ₹367.00 |
| Total Expenses | ₹463.65 | ₹490.35 | ₹548.91 | ₹444.40 |
| Profit Before Tax | -₹30.83 | -₹103.00 | -₹96.20 | -₹83.31 |
| Tax | -₹20.96 | -₹26.59 | -₹37.33 | -₹52.84 |
| Profit After Tax | -₹9.87 | -₹76.41 | -₹58.87 | -₹30.47 |
| EPS - Basic | -₹0.63 | -₹4.87 | -₹3.75 | -₹2.01 |
| EPS - Diluted | -₹0.63 | -₹4.87 | -₹3.75 | -₹2.01 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | -₹30.83 | -₹103.00 | -₹96.20 | -₹84.39 |
| Income before WC changes | ₹64.84 | ₹13.86 | ₹4.76 | ₹32.93 |
| Change in Assets | ₹42.99 | -₹12.06 | -₹72.63 | ₹14.00 |
| Change in Liabilities | -₹49.75 | ₹23.59 | ₹18.52 | ₹186.55 |
| Change in WC | -₹6.76 | ₹11.53 | -₹54.11 | ₹200.55 |
| Cash flow from Operations | ₹55.81 | ₹24.17 | -₹52.90 | ₹227.35 |
| Cash flow from Investing | -₹79.64 | ₹96.57 | ₹40.71 | -₹172.67 |
| Cash flow from Financing | ₹87.51 | -₹130.76 | ₹1.38 | -₹46.16 |
| Total Cash Flow | ₹63.68 | -₹10.02 | -₹10.81 | ₹8.52 |
| Cash (Start of the year) | ₹4.05 | ₹14.07 | ₹24.88 | ₹16.36 |
| Cash (End of the year) | ₹67.73 | ₹4.05 | ₹14.07 | ₹24.88 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹4,447.37 | ₹4,489.44 | ₹4,531.43 | ₹4,448.52 |
| Current Assets | ₹674.98 | ₹587.22 | ₹649.61 | ₹765.79 |
| Total Assets | ₹5,122.35 | ₹5,076.66 | ₹5,181.04 | ₹5,214.31 |
| Current Liabilities | ₹652.10 | ₹618.73 | ₹641.60 | ₹551.19 |
| Net Current Asset | ₹22.88 | -₹31.51 | ₹8.01 | ₹214.60 |
| Non-Current Liabilities | ₹439.77 | ₹405.35 | ₹425.13 | ₹431.34 |
| Equity Capital | ₹4,030.48 | ₹4,052.58 | ₹4,114.31 | ₹4,231.78 |
| Total Equity & Liabilities | ₹5,122.35 | ₹5,076.66 | ₹5,181.04 | ₹5,214.31 |
Dishman Carbogen Amcis Limited is engaged in offering contract research and manufacturing services (CRAMS) and the manufacture and supply of marketable molecules such as specialty chemicals, vitamins and chemicals, and disinfectants. Its segments include CRAMS and Marketable Molecules. The CRAMS segment includes Contract Research Services and Contract Manufacturing Services, which it offers to its customers. Through its CRAMS business, the Company assists drug manufacturers in the development and optimization of processes for novel drug molecules in various stages of the development process. The Marketable Molecules segment manufactures and supplies intermediates, quaternary compounds, specialty chemicals, and various products for pharmaceuticals and cosmetics. It has manufacturing and research facilities in India, Switzerland, France, the Netherlands, the United Kingdom, and China. Its subsidiaries include CARBOGEN AMCIS (Shanghai) Co. Ltd, Dishman Infrastructure Ltd., and others.
Dishman Carbo share price is ₹196.54 as on 03 Jul, 2026, 15:58 IST.
In the last 1 year, Dishman Carbo delivered a return of -23.21%. The Dishman Carbo share price hit a high of ₹321.95 and low of ₹128.50.
The Mutual Fund Shareholding in Dishman Carbo was 1.06% at the end of Mar 2026.
The 52-week high and low of Dishman Carbo share is ₹321.95 and ₹128.50 as of 03 Jul, 2026.
The market capitalisation of Dishman Carbo is ₹2,947.52 Crores as on 03 Jul, 2026.
The stock symbol of Dishman Carbo is DCAL on the NSE, 540701 on the BSE, and the ISIN is INE385W01011.
Dishman Carbo shares closed yesterday at ₹187.75 on NSE & ₹188.00 on BSE
To buy Dishman Carbo shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
No, shares of Dishman Carbo or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Dishman Carbo shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
The PE and PB ratio of Dishman Carbo is 30.23 and 0.44 respectively, as on 03 Jul, 2026, 15:58 IST.